Taste and smell disturbances in patients with chronic oral graft vs. host disease: An observational study

被引:1
作者
Boor, Marlou [1 ,2 ]
Raber-Durlacher, Judith E. [1 ,2 ,3 ]
Hazenberg, Mette D. [4 ]
Rozema, Frederik R. [1 ,2 ,3 ]
Laheij, Alexa M. G. A. [1 ,2 ,3 ,5 ]
机构
[1] Univ Amsterdam, Acad Ctr Dent ACTA, Dept Oral Med, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Oral Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands
[4] Univ Amsterdam, Dept Hematol Amsterdam UMC, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Ctr Dent ACTA, Dept Prevent Dent, Amsterdam, Netherlands
来源
FRONTIERS IN ORAL HEALTH | 2022年 / 3卷
关键词
hyposalivation; hypogeusia; quality of life; allogeneic hematopoietic stem cell transplantation (alloHSCT); chronic oral graft-vs; -host disease; taste and smell disturbances; QUALITY-OF-LIFE; CONSENSUS DEVELOPMENT PROJECT; QUANTITATIVE ASSESSMENT; CLINICAL-TRIALS; HEALTH; CHEMOTHERAPY; IMPACT; RELIABILITY; VALIDATION; DYSGEUSIA;
D O I
10.3389/froh.2022.934607
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BackgroundA common complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) is chronic oral graft vs. host disease (cGvHD). Oral cGvHD may present as mucosal lesions, salivary gland dysfunction, and trismus. Moreover, taste and smell ability may be affected, but the prevalence, nature and severity of altered taste and smell function, and their impact on quality of life (QoL) are understudied. AimTo identify the prevalence, nature, and severity of taste and smell disturbances, their impact on QoL and to assess whether altered taste/smell ability is associated with oral mucosal cGvHD or hyposalivation. Materials and methodsAlloHSCT recipients at least 100 days post-HSCT and referred for oral cGvHD-related oral complaints were eligible for participation in this cross-sectional study. Manifestations of oral mucosal cGvHD were scored, the (un)stimulated salivary flow was measured, and objective taste and smell ability was evaluated. Subjective taste and smell alterations, and overall and oral health (OH)-related QoL were assessed. ResultsIn total, 45 patients were included, of which objective reduced taste ability (hypogeusia) was identified in 68.9%; 28.9% had reduced smell ability and 11.1% had complete loss of smell. Nevertheless, only 31.1% of patients reported severe taste alterations and 22% reported moderate taste alterations indicating that not all the patients were aware of their altered taste sense. Taste/smell disturbances were not related to oral mucosal cGvHD or hyposalivation. Most alloHSCT recipients reported a decreased OH-related QoL. However, a relation between taste/smell ability and global or OH-related QoL could not be identified. ConclusionTaste and smell disturbances are prevalent among alloHSCT recipients. Most patients reported a decreased OH-related QoL, but the specific impact of taste and smell disturbances remains to be elucidated.
引用
收藏
页数:12
相关论文
共 41 条
  • [1] Chemosensory changes and quality of life in patients undergoing hematopoietic stem cell transplantation
    Abasaeed, Rania
    Coldwell, Susan E.
    Lloid, Michele E.
    Soliman, Sohaib H.
    Macris, Paula C.
    Schubert, Mark M.
    [J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (10) : 3553 - 3561
  • [2] Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT
    Boer, C. C.
    Correa, M. E. P.
    Miranda, E. C. M.
    de Souza, C. A.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (04) : 705 - 711
  • [3] The influence of chemotherapy on taste perception and food hedonics: A systematic review
    Boltong, Anna
    Keast, Russell
    [J]. CANCER TREATMENT REVIEWS, 2012, 38 (02) : 152 - 163
  • [4] Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge
    Comeau, TB
    Epstein, JB
    Migas, C
    [J]. SUPPORTIVE CARE IN CANCER, 2001, 9 (08) : 575 - 580
  • [5] The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
    Cooke, Kenneth R.
    Luznik, Leo
    Sarantopoulos, Stefanie
    Hakim, Frances T.
    Jagasia, Madan
    Fowler, Daniel H.
    van den Brink, Marcel R. M.
    Hansen, John A.
    Parkman, Robertson
    Miklos, David B.
    Martin, Paul J.
    Paczesny, Sophie
    Vogelsang, Georgia
    Pavletic, Steven
    Ritz, Jerome
    Schultz, Kirk R.
    Blazar, Bruce R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 211 - 234
  • [6] Drug-induced taste disorders
    Doty, Richard L.
    Shah, Muhammad
    Bromley, Steven M.
    [J]. DRUG SAFETY, 2008, 31 (03) : 199 - 215
  • [7] Effects of drugs on olfaction and taste
    Doty, RL
    Bromley, SM
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2004, 37 (06) : 1229 - +
  • [8] Validation of The National Institutes of Health (NIH) Scale for Oral Chronic Graft-versus-Host Disease (cGVHD)
    Elad, Sharon
    Zeevi, Itai
    Or, Reuven
    Resnick, Igor B.
    Dray, Lilian
    Shapira, Michael Y.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : 62 - 69
  • [9] Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation
    Epstein, JB
    Phillips, N
    Parry, J
    Epstein, MS
    Nevill, T
    Stevenson-Moore, P
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (11) : 785 - 792
  • [10] Taste disorders in cancer patients: Pathogenesis, and approach to assessment and management
    Epstein, Joel B.
    Barasch, Andrei
    [J]. ORAL ONCOLOGY, 2010, 46 (02) : 77 - 81